143 related articles for article (PubMed ID: 21549308)
1. Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions.
Zhao Y; Abreu E; Kim J; Stadler G; Eskiocak U; Terns MP; Terns RM; Shay JW; Wright WE
Mol Cell; 2011 May; 42(3):297-307. PubMed ID: 21549308
[TBL] [Abstract][Full Text] [Related]
2. An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity.
Gazzaniga FS; Blackburn EH
Blood; 2014 Dec; 124(25):3675-84. PubMed ID: 25320237
[TBL] [Abstract][Full Text] [Related]
3. Human telomerase and its regulation.
Cong YS; Wright WE; Shay JW
Microbiol Mol Biol Rev; 2002 Sep; 66(3):407-25, table of contents. PubMed ID: 12208997
[TBL] [Abstract][Full Text] [Related]
4. DNA-binding determinants and cellular thresholds for human telomerase repeat addition processivity.
Wu RA; Tam J; Collins K
EMBO J; 2017 Jul; 36(13):1908-1927. PubMed ID: 28495680
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of telomerase inhibition by oxidized and therapeutic dNTPs.
Sanford SL; Welfer GA; Freudenthal BD; Opresko PL
Nat Commun; 2020 Oct; 11(1):5288. PubMed ID: 33082336
[TBL] [Abstract][Full Text] [Related]
6. Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1.
Freund A; Zhong FL; Venteicher AS; Meng Z; Veenstra TD; Frydman J; Artandi SE
Cell; 2014 Dec; 159(6):1389-403. PubMed ID: 25467444
[TBL] [Abstract][Full Text] [Related]
7. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells.
Koziel JE; Herbert BS
Breast Cancer Res Treat; 2015 Feb; 149(3):607-18. PubMed ID: 25627551
[TBL] [Abstract][Full Text] [Related]
8. Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor.
Hu Y; Bobb D; Lu Y; He J; Dome JS
Cancer Genet; 2014 Sep; 207(9):403-11. PubMed ID: 25441685
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
[TBL] [Abstract][Full Text] [Related]
10. Novel anticancer therapeutics targeting telomerase.
Ruden M; Puri N
Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
[TBL] [Abstract][Full Text] [Related]
11. Human cells lacking coilin and Cajal bodies are proficient in telomerase assembly, trafficking and telomere maintenance.
Chen Y; Deng Z; Jiang S; Hu Q; Liu H; Songyang Z; Ma W; Chen S; Zhao Y
Nucleic Acids Res; 2015 Jan; 43(1):385-95. PubMed ID: 25477378
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing regulation of telomerase: a new paradigm?
Wong MS; Wright WE; Shay JW
Trends Genet; 2014 Oct; 30(10):430-8. PubMed ID: 25172021
[TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.
Burchett KM; Yan Y; Ouellette MM
PLoS One; 2014; 9(1):e85155. PubMed ID: 24409321
[TBL] [Abstract][Full Text] [Related]
14. Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy.
Stadler G; Rahimov F; King OD; Chen JC; Robin JD; Wagner KR; Shay JW; Emerson CP; Wright WE
Nat Struct Mol Biol; 2013 Jun; 20(6):671-8. PubMed ID: 23644600
[TBL] [Abstract][Full Text] [Related]
15. Telomerase and telomere-associated proteins: structural insights into mechanism and evolution.
Lewis KA; Wuttke DS
Structure; 2012 Jan; 20(1):28-39. PubMed ID: 22244753
[TBL] [Abstract][Full Text] [Related]
16. Telomerase regulation.
Cifuentes-Rojas C; Shippen DE
Mutat Res; 2012 Feb; 730(1-2):20-7. PubMed ID: 22032831
[TBL] [Abstract][Full Text] [Related]
17. Guardians of the Genome: How the Single-Stranded DNA-Binding Proteins RPA and CST Facilitate Telomere Replication.
Olson CL; Wuttke DS
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540683
[TBL] [Abstract][Full Text] [Related]
18. Telomere length is an epigenetic trait - Implications for the use of telomerase-deficient organisms to model human disease.
Henriques CM; Ferreira MG
Dis Model Mech; 2024 Mar; 17(3):. PubMed ID: 38441152
[TBL] [Abstract][Full Text] [Related]
19. Models for human telomere C-strand fill-in by CST-Polα-primase.
He Q; Lim CJ
Trends Biochem Sci; 2023 Oct; 48(10):860-872. PubMed ID: 37586999
[TBL] [Abstract][Full Text] [Related]
20. CTC1 OB-B interaction with TPP1 terminates telomerase and prevents telomere overextension.
Wang H; Ma T; Zhang X; Chen W; Lan Y; Kuang G; Hsu SJ; He Z; Chen Y; Stewart J; Bhattacharjee A; Luo Z; Price C; Feng X
Nucleic Acids Res; 2023 Jun; 51(10):4914-4928. PubMed ID: 37021555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
